ENTITY
Regeneron Pharmaceuticals

Regeneron Pharmaceuticals (REGN US)

128
Analysis
Health CareUnited States
Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders.
more
11 Nov 2024 14:00

Regeneron Pharmaceuticals: Expansion of Dupixent to Additional Indications & Other Key Developments! - Major Drivers

Regeneron Pharmaceuticals reported a solid financial and operational performance for the third quarter of 2024, highlighting key successes but...

Logo
118 Views
Share
11 Aug 2024 03:00

Regeneron Pharmaceuticals: A Deep Dive Into Bear's Perspective! - Major Drivers

Regeneron Pharmaceuticals reported substantial growth in its second quarter of 2024, with a 12% increase in total revenues to $3.55 billion. This...

Logo
223 Views
Share
16 May 2024 02:00

Regeneron Pharmaceuticals Inc.: What Is The Growth Potential For Libtayo & Other Products? - Major Drivers

Regeneron Pharmaceuticals, Inc. reported robust financial results for first quarter of 2024, exhibiting a solid start to the year apparent in the...

Logo
173 Views
Share
17 Apr 2024 15:00

Regeneron Pharmaceuticals: Bolstering Cell Therapy Research with 2seventy Bio Acquisition! - Major Drivers

Regeneron Pharmaceuticals Inc.'s latest earnings highlighted several critical developments and financial performance data that shape its...

Logo
184 Views
Share
12 Jan 2024 15:08

Regeneron Pharmaceuticals Inc.: Gene Therapy Breakthrough in Hearing Loss - A Medical Revolution? - Major Drivers

Regeneron Pharmaceuticals, Inc. delivered an all-around beat in the previous quarter, witnessing a commendable 15% surge in total revenues. The...

Logo
368 Views
Share
x